← Back to Search

68Ga-PSMA-11 PET/MRI for Liver Cancer

Phase < 1
Waitlist Available
Led By Ajit H Goenka, MD
Research Sponsored by Ajit H. Goenka, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights

Study Summary

This study is evaluating whether a drug/radiopharmaceutical may be useful in evaluating liver cancer.

Eligible Conditions
  • Liver Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Evaluation of PSMA PET-MR for identification of intra and extrahepatic hepatocellular carcinoma in patients

Trial Design

1Treatment groups
Experimental Treatment
Group I: Ga68 PSMA PET-MRExperimental Treatment1 Intervention
68Ga labeled PSMA -11 (or PSMA-HBED_CC) PET/MRI scan
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
68Ga-PSMA-11 PET/MRI
2019
Completed Early Phase 1
~10

Find a Location

Who is running the clinical trial?

Ajit H. Goenka, MDLead Sponsor
Ajit H Goenka, MDPrincipal InvestigatorMayo Clinic

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
68 Ga PSMA PET/MRI for Hepatocellular Carcinoma
Ajit H. Goenka, MD 2019. "68 Ga PSMA PET/MRI for Hepatocellular Carcinoma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03982407.
~1 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top